Global Iron Chelation Drug Market Research Report 2023(Status and Outlook)

Global Iron Chelation Drug Market Research Report 2023(Status and Outlook)



Report Overview

In a healthy body, when the stores of iron are sufficient, the intestines reduce the absorption of this mineral from food and drink to prevent its levels from rising too high.

People with iron overload disorders absorb more iron than usual from food or supplements. The body cannot excrete the extra iron fast enough, so it continues to build up. The body stores it in organ tissue, mainly in the liver, as well as the heart and the pancreas.

There are several types of iron overload disorder. Hereditary hemochromatosis is a primary condition that has a genetic component. People can also have secondary hemochromatosis, which develops as a result of another disease or condition.

The rationale behind using Iron chelation therapy is removing the increased iron burden specifically labile cell iron (LCI) to minimize production of reactive oxygen species (ROS) thereby decreasing cellular and organ damage. Patients most likely to benefit from chelation therapy include those with low or intermediate-1 IPSS risk MDS who have a long-life expectancy and are anticipated to receive more than 20 red blood cell transfusions and/or whose serum ferritin level is >1000 μg/L. Chelation therapy efficacy can be monitored by monitoring trends and levels of serum ferritin.

Global Iron Chelation Drug key players include Novartis, Chiesi Group, Sun Pharma, Cipla, Natco Pharma, etc. Global top five manufacturers hold a Revenue Market Share over 35%. Europe accounts for the most Sales Market Share, which have a share over 40%, followed by North America. In terms of product, Deferasirox is the largest segment, with a Revenue Market Share over 90%. And in terms of application, the largest Application is Transfusional Iron Overload, followed by NTDT Caused Iron Overload.

The Global Iron Chelation Drug Market Size was estimated at USD 785.00 million in 2022 and is projected to reach USD 475.90 million by 2029, exhibiting a CAGR of -6.90% during the forecast period.

Bosson Research’s latest report provides a deep insight into the global Iron Chelation Drug market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Iron Chelation Drug Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Iron Chelation Drug market in any manner.

Global Iron Chelation Drug Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

Novartis

Chiesi Group

Sun Pharma

Cipla

Natco Pharma

Taro Pharm

Gland Pharma

Market Segmentation (by Type)

Deferasirox

Deferoxamine

Deferiprone

Market Segmentation (by Application)

Indoor Application

Outdoor Application

Geographic Segmentation

North America (USA, Canada, Mexico)

Europe (Germany, UK, France, Russia, Italy, Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)

South America (Brazil, Argentina, Columbia, Rest of South America)

The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)

Key Benefits of This Market Research:

Industry drivers, restraints, and opportunities covered in the study

Neutral perspective on the market performance

Recent industry trends and developments

Competitive landscape & strategies of key players

Potential & niche segments and regions exhibiting promising growth covered

Historical, current, and projected market size, in terms of value

In-depth analysis of the Iron Chelation Drug Market

Overview of the regional outlook of the Iron Chelation Drug Market:

Key Reasons to Buy this Report:

Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change

This enables you to anticipate market changes to remain ahead of your competitors


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Iron Chelation Drug
1.2 Key Market Segments
1.2.1 Iron Chelation Drug Segment by Type
1.2.2 Iron Chelation Drug Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Iron Chelation Drug Market Overview
2.1 Global Market Overview
2.1.1 Global Iron Chelation Drug Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global Iron Chelation Drug Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Iron Chelation Drug Market Competitive Landscape
3.1 Global Iron Chelation Drug Sales by Manufacturers (2018-2023)
3.2 Global Iron Chelation Drug Revenue Market Share by Manufacturers (2018-2023)
3.3 Iron Chelation Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Iron Chelation Drug Average Price by Manufacturers (2018-2023)
3.5 Manufacturers Iron Chelation Drug Sales Sites, Area Served, Product Type
3.6 Iron Chelation Drug Market Competitive Situation and Trends
3.6.1 Iron Chelation Drug Market Concentration Rate
3.6.2 Global 5 and 10 Largest Iron Chelation Drug Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Iron Chelation Drug Industry Chain Analysis
4.1 Iron Chelation Drug Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Iron Chelation Drug Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Iron Chelation Drug Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Iron Chelation Drug Sales Market Share by Type (2018-2023)
6.3 Global Iron Chelation Drug Market Size Market Share by Type (2018-2023)
6.4 Global Iron Chelation Drug Price by Type (2018-2023)
7 Iron Chelation Drug Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Iron Chelation Drug Market Sales by Application (2018-2023)
7.3 Global Iron Chelation Drug Market Size (M USD) by Application (2018-2023)
7.4 Global Iron Chelation Drug Sales Growth Rate by Application (2018-2023)
8 Iron Chelation Drug Market Segmentation by Region
8.1 Global Iron Chelation Drug Sales by Region
8.1.1 Global Iron Chelation Drug Sales by Region
8.1.2 Global Iron Chelation Drug Sales Market Share by Region
8.2 North America
8.2.1 North America Iron Chelation Drug Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Iron Chelation Drug Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Iron Chelation Drug Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Iron Chelation Drug Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Iron Chelation Drug Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Novartis
9.1.1 Novartis Iron Chelation Drug Basic Information
9.1.2 Novartis Iron Chelation Drug Product Overview
9.1.3 Novartis Iron Chelation Drug Product Market Performance
9.1.4 Novartis Business Overview
9.1.5 Novartis Iron Chelation Drug SWOT Analysis
9.1.6 Novartis Recent Developments
9.2 Chiesi Group
9.2.1 Chiesi Group Iron Chelation Drug Basic Information
9.2.2 Chiesi Group Iron Chelation Drug Product Overview
9.2.3 Chiesi Group Iron Chelation Drug Product Market Performance
9.2.4 Chiesi Group Business Overview
9.2.5 Chiesi Group Iron Chelation Drug SWOT Analysis
9.2.6 Chiesi Group Recent Developments
9.3 Sun Pharma
9.3.1 Sun Pharma Iron Chelation Drug Basic Information
9.3.2 Sun Pharma Iron Chelation Drug Product Overview
9.3.3 Sun Pharma Iron Chelation Drug Product Market Performance
9.3.4 Sun Pharma Business Overview
9.3.5 Sun Pharma Iron Chelation Drug SWOT Analysis
9.3.6 Sun Pharma Recent Developments
9.4 Cipla
9.4.1 Cipla Iron Chelation Drug Basic Information
9.4.2 Cipla Iron Chelation Drug Product Overview
9.4.3 Cipla Iron Chelation Drug Product Market Performance
9.4.4 Cipla Business Overview
9.4.5 Cipla Iron Chelation Drug SWOT Analysis
9.4.6 Cipla Recent Developments
9.5 Natco Pharma
9.5.1 Natco Pharma Iron Chelation Drug Basic Information
9.5.2 Natco Pharma Iron Chelation Drug Product Overview
9.5.3 Natco Pharma Iron Chelation Drug Product Market Performance
9.5.4 Natco Pharma Business Overview
9.5.5 Natco Pharma Iron Chelation Drug SWOT Analysis
9.5.6 Natco Pharma Recent Developments
9.6 Taro Pharm
9.6.1 Taro Pharm Iron Chelation Drug Basic Information
9.6.2 Taro Pharm Iron Chelation Drug Product Overview
9.6.3 Taro Pharm Iron Chelation Drug Product Market Performance
9.6.4 Taro Pharm Business Overview
9.6.5 Taro Pharm Recent Developments
9.7 Gland Pharma
9.7.1 Gland Pharma Iron Chelation Drug Basic Information
9.7.2 Gland Pharma Iron Chelation Drug Product Overview
9.7.3 Gland Pharma Iron Chelation Drug Product Market Performance
9.7.4 Gland Pharma Business Overview
9.7.5 Gland Pharma Recent Developments
10 Iron Chelation Drug Market Forecast by Region
10.1 Global Iron Chelation Drug Market Size Forecast
10.2 Global Iron Chelation Drug Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Iron Chelation Drug Market Size Forecast by Country
10.2.3 Asia Pacific Iron Chelation Drug Market Size Forecast by Region
10.2.4 South America Iron Chelation Drug Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Iron Chelation Drug by Country
11 Forecast Market by Type and by Application (2024-2029)
11.1 Global Iron Chelation Drug Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of Iron Chelation Drug by Type (2024-2029)
11.1.2 Global Iron Chelation Drug Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of Iron Chelation Drug by Type (2024-2029)
11.2 Global Iron Chelation Drug Market Forecast by Application (2024-2029)
11.2.1 Global Iron Chelation Drug Sales (K MT) Forecast by Application
11.2.2 Global Iron Chelation Drug Market Size (M USD) Forecast by Application (2024-2029)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings